Search results
What should people know about the new coronavirus variant? A doctor explains.
CNN via Yahoo News· 2 days agoThe Covid-19 variant KP.2 has become the dominant strain in the US in recent weeks. We talked to our...
Japan's Shionogi says COVID treatment did not meet endpoint in late-stage trial
Reuters via Yahoo News· 2 weeks agoWHY ...November 2022, making it the nation's first domestically produced oral treatment for COVID....
Covid inquiry: What is it investigating and how does it work?
BBC via Yahoo News· 2 weeks agoKirsten Heaven, counsel for the Covid-19 Bereaved Families Cymru: said there had been a "passive,...
NanoViricides shares gain as new data shows lead drug asset's strong activity against RSV
Proactive Investors· 2 weeks agoNanoViricides (NYSE-A:NNVC) has released new data which shows the strength of the antiviral activity...
Earnings call: Atea Pharmaceuticals reports progress in COVID-19 trial By Investing.com
Investing.com· 2 weeks agoAdditionally, Atea provided an update on its hepatitis C (HCV) program, including positive results...
Moderna’s long Covid plan
Politico· 2 days agoEven so: Rizkalla said Moderna...What’s next? Rizkalla said he sees some promise in antiviral treatments, which may clear residual virus after an...
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA TODAY via Yahoo News· 3 days agoThe Haitian man and woman Williams had met through a local church program and asked about antiviral...
‘No reason to panic’ in Singapore, even with latest wave of Covid-19 infections
South China Morning Post· 17 hours agoHealth Minister Ong Ye Kung urged the elderly and vulnerable to get an additional dose of the...
CDC calls risk low, but is preparing against easier bird flu spread to people
Deseret News via Yahoo News· 23 hours ago“It is critical that you work swiftly to get ahead of this emerging situation and reassure the...
Atea Pharmaceuticals Inc (AVIR) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress ...
GuruFocus.com via Yahoo Finance· 1 week agoThe company faces intense competition in the COVID-19 treatment market, with only two approved antiviral products ...
